Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Aristo Bio-Tech&Lis

₹78 0 | 0%

Market Cap ₹53 Cr.

Stock P/E 0.0

P/B 1.8

Current Price ₹78

Book Value ₹ 44.3

Face Value 10

52W High ₹101.9

Dividend Yield 0%

52W Low ₹ 53.1

Aristo Bio-Tech&Lis Research see more...

Overview Inc. Year: 2005Industry: Pesticides & Agrochemicals

Aristo Bio-Tech&Lis Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Aristo Bio-Tech&Lis Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Aristo Bio-Tech&Lis Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 202 201 167 166 218
Other Income 0 0 0 0 0
Total Income 202 201 167 166 218
Total Expenditure 195 197 163 161 209
Operating Profit 7 5 5 5 9
Interest 2 3 2 2 3
Depreciation 1 1 1 1 2
Exceptional Income / Expenses -0 0 0 0 0
Profit Before Tax 4 1 1 2 5
Provision for Tax 1 0 0 1 1
Profit After Tax 3 1 1 1 4
Adjustments 0 0 0 0 0
Profit After Adjustments 3 1 1 1 4
Adjusted Earnings Per Share 5.7 2 2.2 2.9 5.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 31% 3% 0% 0%
Operating Profit CAGR 80% 22% 0% 0%
PAT CAGR 300% 59% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 32% NA% NA% NA%
ROE Average 16% 11% 14% 14%
ROCE Average 16% 13% 15% 15%

Aristo Bio-Tech&Lis Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 11 12 13 15 30
Minority's Interest 0 0 0 0 0
Borrowings 7 11 12 11 10
Other Non-Current Liabilities -0 -0 0 0 0
Total Current Liabilities 72 65 56 51 59
Total Liabilities 91 88 81 77 100
Fixed Assets 8 8 12 14 16
Other Non-Current Assets 2 3 0 0 1
Total Current Assets 81 77 69 63 83
Total Assets 91 88 81 77 100

Aristo Bio-Tech&Lis Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 1 0 0
Cash Flow from Operating Activities 8 1 2 7 -3
Cash Flow from Investing Activities -2 -2 -2 -3 -4
Cash Flow from Financing Activities -6 1 -1 -3 8
Net Cash Inflow / Outflow -0 0 -0 0 1
Closing Cash & Cash Equivalent 0 1 0 0 2

Aristo Bio-Tech&Lis Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 5.66 2.02 2.15 2.87 5.23
CEPS(Rs) 6.68 3.06 3.65 5.07 7.49
DPS(Rs) 0 0 0 0 0.25
Book NAV/Share(Rs) 22.62 24.63 26.79 29.76 44.3
Core EBITDA Margin(%) 2.91 1.91 2.22 3.12 3.99
EBIT Margin(%) 2.71 1.7 1.94 2.62 3.44
Pre Tax Margin(%) 1.75 0.59 0.76 1.19 2.18
PAT Margin (%) 1.21 0.43 0.55 0.86 1.64
Cash Profit Margin (%) 1.42 0.65 0.93 1.53 2.34
ROA(%) 3.12 1.13 1.27 1.81 4.03
ROE(%) 25.03 8.54 8.38 10.15 15.82
ROCE(%) 24.67 13.84 11.27 11.43 16.11
Receivable days 65.74 70.19 75.46 72.63 65.15
Inventory Days 51.31 44.41 52.38 61.99 46.19
Payable days 124.02 97.68 92.64 91.29 75.14
PER(x) 0 0 0 0 10.71
Price/Book(x) 0 0 0 0 1.27
Dividend Yield(%) 0 0 0 0 0.45
EV/Net Sales(x) 0.09 0.12 0.16 0.18 0.27
EV/Core EBITDA(x) 2.74 5.35 5.95 5.52 6.51
Net Sales Growth(%) 0 -0.22 -16.9 -0.87 31.36
EBIT Growth(%) 0 -37.07 -4.62 13.95 72.49
PAT Growth(%) 0 -64.38 6.78 33.29 148.44
EPS Growth(%) 0 -64.38 6.78 33.29 82.29
Debt/Equity(x) 1.28 1.6 1.66 1.71 0.75
Current Ratio(x) 1.12 1.18 1.23 1.23 1.4
Quick Ratio(x) 0.66 0.81 0.66 0.75 0.88
Interest Cover(x) 2.82 1.54 1.65 1.84 2.72
Total Debt/Mcap(x) 0 0 0 0 0.59

Aristo Bio-Tech&Lis Shareholding Pattern

# Mar 2023 Sep 2023 Mar 2024
Promoter 73.37 73.37 73.37
FII 0 0 0
DII 0 0 0
Public 26.63 26.63 26.63
Others 0 0 0
Total 100 100 100

Pros

  • Debtor days have improved from 91.29 to 75.14days.
  • Company has reduced debt.

Cons

  • Company has a low return on equity of 11% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Aristo Bio-Tech&Lis News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....